Surgical outcomes for cytoreductive nephrectomy in tyrosine kinase inhibitor treated and untreated patients: a matched pair analysis

被引：0
|
作者：
Laird, A. [1 ]
Stewart, G. D. [1 ]
McNeill, S. A. [1 ]
O'Brien, T. S. [1 ]
Keeley, F. X. [1 ]
Fowler, S. [1 ]
机构：
[1] Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
BJU INTERNATIONAL | 2014年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Complications associated with perioperative use of tyrosine kinase inhibitor in cytoreductive nephrectomy
    Filipe L. F. Carvalho
    Chaoyi Zheng
    Kenneth Witmer
    John O’neill
    John H. Lynch
    Keith J. Kowalczyk
    [J]. Scientific Reports, 9
  • [2] Complications associated with perioperative use of tyrosine kinase inhibitor in cytoreductive nephrectomy
    Carvalho, Filipe L. F.
    Zheng, Chaoyi
    Witmer, Kenneth
    O'neill, John
    Lynch, John H.
    Kowalczyk, Keith J.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
    Meagher, Margaret F.
    Minervini, Andrea
    Mir, Maria C.
    Cerrato, Clara
    Rebez, Giacomo
    Autorino, Riccardo
    Hampton, Lance
    Campi, Riccardo
    Kriegmair, Maximilian
    Linares, Estefania
    Hevia, Vital
    Musquera, Maria
    D'Anna, Mauricio
    Roussel, Eduard
    Albersen, Maarten
    Pavan, Nicola
    Claps, Francesco
    Antonelli, Alessandro
    Marchioni, Michele
    Paksoy, Nail
    Erdem, Selcuk
    Derweesh, Ithaar H.
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2024, 63 : 71 - 80
  • [4] SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR
    Lo, Jing Zhi
    Sunaryo, Peter
    Paulucci, David
    Badani, Ketan
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E867 - E867
  • [5] Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered
    Stewart, Grant D.
    Aitchison, Michael
    Bex, Axel
    Larkin, James
    Lawless, Claire
    Mejean, Arnaud
    Nathan, Paul
    Oades, Grenville
    Patard, Jean-Jacques
    Paul, James
    Ravaud, Alain
    Escudier, Bernard
    [J]. EUROPEAN UROLOGY, 2017, 71 (06) : 845 - 847
  • [6] The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort
    Janisch, Florian
    Hillemacher, Tobias
    Fuehner, Constantin
    D'Andrea, David
    Meyer, Christian P.
    Klotzbucher, Thomas
    Kienapfel, Christina
    Vetterlein, Malte W.
    Kimura, Shoji
    Abufaraj, Mohammad
    Dahlem, Roland
    Shariat, Shahrokh F.
    Fisch, Margit
    Rink, Michael
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (09) : 739.e9 - 739.e15
  • [7] Impact of tyrosine kinase inhibitors and cytoreductive nephrectomy in patients with metastatic renal cell carcinoma
    Kassouf, Wassim
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (04): : 292 - 292
  • [8] Trends in the use of cytoreductive nephrectomy for metastatic renal cell carcinoma in the VEGFR tyrosine kinase inhibitor era
    Tsao, Che-Kai
    Small, Alexander C.
    Kates, Max
    Gartrell, Benjamin Adam
    Wisnivesky, Juan P.
    Sonpavde, Guru
    Palese, Michael
    Hall, Simon
    Oh, William K.
    Galsky, Matt D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
    Hatakeyama, Shingo
    Naito, Sei
    Numakura, Kazuyuki
    Kato, Renpei
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Kandori
    Tsushima, Eiki
    Nishiyama, Hiroyuki
    Ito, Akihiro
    Kojima, Yoshiyuki
    Habuchi, Tomonori
    Obara, Wataru
    Tsuchiya, Norihiko
    Ohyama, Chikara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [10] Cytoreductive Nephrectomy in Metastatic Clear-Cell Renal Cell Carcinoma: Perspectives in the Tyrosine Kinase Inhibitor Era
    Biswas, Swethajit
    Kelly, John
    Eisen, Tim
    [J]. ONCOLOGIST, 2009, 14 (01): : 52 - 59
12345